The BAP is a learned society and registered charity. It promotes research and education in psychopharmacology and related areas, and brings together people in academia, health services, and industry. Formed in 1974, it is the largest such national association in Europe, and the second largest in the world.
Summer Meeting 2019Join us in Manchester 14th to 17th July 2019
Not all in the mind – the contribution of brain science to modern psychiatryJoin Prof David Nutt at Newcastle Uni for his Public Lecture, 9th April 2019 at 6pm
Visualising Psychotropic Medicine (VPM)Presenting what can be a complex set of data in a useful and engaging way
Online CPD ResourceRCPsych Online CPD Subscribers get a discount on the BAP Online Resource
Fundamentals of Clinical PsychopharmacologyBuy a discounted copy of the new Fundamentals of Clinical Psychopharmacology
The Ten Secrets of Success in ScienceView Professor Trevor Robbins presenting his top tips
Neuroscience-based Nomenclature (NbN) for JoPJournal of Psychopharmacology chosen to trial new NbN
Fundamentals Wins BMA AwardFundamentals of Clinical Psychopharmacology wins BMA Medical Book Award in Psychiatry
Not all in the mind – the contribution of brain science to modern psychiatryWatch Prof David Nutt's lecture in Manchester on YouTube
Benefits of BAP membership include:
- FREE subscription and access to the Journal of Psychopharmacology (published monthly online).
- Reduced registration fees for the annual Summer Meeting.
- Half price subscription to the Online CPD Resource.
- Eligibility for prizes and awards.
- Student bursaries for the BAP Summer Meeting and international conferences.
- Reduced registration fees for selected partner association events.
- 50% OFF Royal Society of Biology membership (Read more)
- BAP Newsletter.
- Voting for BAP Officers and Council (full members only).
- Being part of one of the largest national psychopharmacology associations in the world.
|28th March 2019||MARC Spring School||Engineers House, Bristol|
|9th April 2019||Public Lecture
Not all in the mind – the contribution of brain science to modern psychiatry
|David Shaw Lecture Theatre, Newcastle University|
|10th April 2019||Day A: Schizophrenia / Substance Misuse||Hallam Conference Centre, 44 Hallam Street, London|
SYMPOSIUM 5: New concepts in the co-morbidity of psychiatric disorders, eating disorders and obesity.
By Sarah Stuart
Posted on 3rd August 2018
Underlying metabolic disturbances are often ignored when treating psychiatric disorders and can even be exacerbated with treatments, but it is becoming more apparent that these metabolic issues may not arise a result of treatment, but may instead be pre-existing in psychosis. This session echoed the theme of schizophrenia and its co-morbidity with eating disorders that […]
SYMPOSIUM 3: Microglia role in neuropsychiatric disease and its potential as a treatment target
By Ciaran Fitzpatrick
Posted on 30th July 2018
(chaired by Valeria Mondelli & Peter Talbot) Given that clinical, genetic and pharmacological findings indicate that inflammatory molecules and their associated pathways are enhanced in neuropsychiatric disorders such as major depressive disorder and schizophrenia, Monday morning’s symposium 3 dealt with the importance of microglia cells in these disorders. Microglia are immune...
Post-Doc Symposium 1: What can animal behaviours really tell us about human cognitive and emotional processes?
By Sarah Stuart
Posted on 30th July 2018
The amount of preclinical data being presented at the BAP Summer Meeting has been dwindling over the years, in favour of clinical and non-clinical human research. This post-doctoral symposium was put together by myself and Dr Claire Hales from the University of Bristol to showcase preclinical work and to highlight the importance of using translational […]
Psychedelics, addiction, and mental health
David talks to ABC Radio National about psychedelics, addiction, and mental health
24th February 2019
Hollywood past saves climber Hamish MacInnes from dementia death sentence
Stephen was quoted in the Times article about how Hamish MacInnes recovered from Dementia with the help of his films and books
22nd February 2019
BBC Radio 5 Live Drive Time - Alcohol Hangover
Chris Alford was talking with Anna and Chloe on BBC Radio 5 Live Drive Time about alcohol hangovers following the recent publication of a study showing that whether beer or wine was drunk first had no effect on the resulting hangover.
8th February 2019
Film and Mental Illness
Stephen Lawrie talks about the portrayal of mental illnesses on film
21st January 2019
MDMA Increases Cooperation and Recruitment of Social Brain Areas When Playing Trustworthy Players in an Iterated Prisoner's Dilemma
Mitul and his team found that participants on MDMA were more willing to cooperate than those given the placebo. Covered by: Live Science, Wired, Vice (German), IFL Science, CTV News.
9th January 2019
|REF2021 Success |
4th February 2019
Prof Allan Young, Prof Jeremy Hall and Prof Helen Cassaday selected to join REF2021 panel 4: Psychology, Psychiatry and Neuroscience
|Professor David Nutt Wins Academic Honorary Award in Istanbul |
9th November 2018
Professor David Nutt has won the Academic Honorary Award at the International Crime and Punishment Film Festival in Istanbul
|Mental health in young people - Press Briefing |
24th July 2018
Press coverage of the successful press briefing on 20th July on the importance of early intervention in mental illness in young people.
|2018 Statistical Excellence in the Pharmaceutical Industry Award |
18th July 2018
Simon Bate and Robin Clark win 2018 Statistical Excellence in the Pharmaceutical Industry Award for their development of InVivoStat
Psychopharmacology is the study of drugs that affect mood, behaviour and cognition. It aims to develop our understanding of the actions and effects of such drugs, which may include treatments for psychiatric disorders as well as substances that can be abused.